Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CILTACABTAGENE AUTOLEUCEL Cause Pyrexia? 242 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 242 reports of Pyrexia have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 6.4% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.

242
Reports of Pyrexia with CILTACABTAGENE AUTOLEUCEL
6.4%
of all CILTACABTAGENE AUTOLEUCEL reports
15
Deaths
147
Hospitalizations

How Dangerous Is Pyrexia From CILTACABTAGENE AUTOLEUCEL?

Of the 242 reports, 15 (6.2%) resulted in death, 147 (60.7%) required hospitalization, and 12 (5.0%) were considered life-threatening.

Is Pyrexia Listed in the Official Label?

Yes, Pyrexia is listed as a known adverse reaction in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL.

What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?

Cytokine release syndrome (570) Immune effector cell-associated neurotoxicity syndrome (232) Parkinsonism (209) Hospitalisation (193) Adverse event (143) Neurotoxicity (140) Death (130) Malaise (126) Fatigue (123) Cranial nerve paralysis (115)

What Other Drugs Cause Pyrexia?

ADALIMUMAB (12,160) METHOTREXATE (10,158) RITUXIMAB (10,061) PREDNISONE (8,141) ETANERCEPT (7,626) INFLIXIMAB (6,560) ACETAMINOPHEN (6,414) CYCLOPHOSPHAMIDE (6,126) TOCILIZUMAB (5,529) LENALIDOMIDE (5,496)

Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Pyrexia Risk?

CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE CILTACABTAGENE AUTOLEUCEL vs CIMZIA CILTACABTAGENE AUTOLEUCEL vs CINACALCET CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE CILTACABTAGENE AUTOLEUCEL vs CINRYZE

Related Pages

CILTACABTAGENE AUTOLEUCEL Full Profile All Pyrexia Reports All Drugs Causing Pyrexia CILTACABTAGENE AUTOLEUCEL Demographics